Literature DB >> 34916250

Covid 19: US cases rise amid omicron fears but booster shots offer protection, experts say.

Janice Hopkins Tanne1.   

Abstract

Entities:  

Year:  2021        PMID： 34916250     DOI： 10.1136/bmj.n3098

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  Front Public Health       Date:  2022-06-17

Review 2.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

Review 3.  Turning point: A new global COVID-19 wave or a signal of the beginning of the end of the global COVID-19 pandemic?

Authors:  Kaixi Ding; Wei Jiang; Chunping Xiong; Ming Lei
Journal:  Immun Inflamm Dis       Date:  2022-04

4.  Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: Current global scenario.

Authors:  Ranjan K Mohapatra; Ashish K Sarangi; Venkataramana Kandi; Mohammad Azam; Ruchi Tiwari; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-01-05       Impact factor: 20.693

5.  Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: A challenging global threat with a special focus on the Indian subcontinent.

Authors:  Ranjan K Mohapatra; Ruchi Tiwari; Ashish K Sarangi; Sanjay K Sharma; Rekha Khandia; G Saikumar; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-02-12       Impact factor: 20.693

6.  Omicron (B.1.1.529) variant of SARS-CoV-2: Concerns, challenges, and recent updates.

Authors:  Ranjan K Mohapatra; Ruchi Tiwari; Ashish K Sarangi; Md Rabiul Islam; Chiranjib Chakraborty; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-02-12       Impact factor: 20.693
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.